The research of Lila J. Rutten, Ph.D., examines social and behavioral factors related to cancer prevention and control. Specifically, her research is focused on implementation and evaluation of evidenced-based cancer prevention and control strategies to improve population health.
- Social and behavioral epidemiologic research to characterize population adoption of cancer prevention and screening services and to identify populations at risk
- Survey research to ascertain multilevel factors associated with population and health care provider adherence to cancer prevention and control recommendations
- Development, implementation and evaluation of multilevel interventions informed by behavioral theory to improve population adoption of cancer prevention and control services
- Content areas of specific focus include human papillomavirus (HPV) vaccination and evidence-based cancer screening, including breast, cervical and colorectal cancer screening
Significance to patient care
Dr. Rutten's program of research involves several pragmatic trials to evaluate the implementation and impact of evidence-based cancer prevention and control strategies in clinical practice.
- Board member, Collaborative for Healthcare Delivery Science Advisory Board, Medical College of Wisconsin, 2018-present
- Member delegate, Board of directors and executive committee, Society of Behavioral Medicine, 2018-2021
- Fellow, Training Institute for Dissemination and Implementation Research in Cancer, National Cancer Institute, 2018
- Member, Roundtable on Population Health Improvement, National Academy of Science, 2013-2016
- Chair, Program Committee, Society of Behavioral Medicine, 2014-2015
- Recipient, National Cancer Institute Directors Award: Informatics for consumer health for leadership in bridging science to practice in the field of consumer health informatics, 2011